Dr. Surender Kumar Dabas – Best Surgical Oncologist
In the realm of cancer treatment, advancements in surgical techniques have played a crucial role in improving patient outcomes and quality of life. Among the pioneers in this field, Dr. Surender Kumar Dabas, a distinguished Surgical Oncology & Robotic Surgery Specialist, has emerged as a trailblazer. With over two decades of experience and an impressive track record of performing complex cancer surgeries, Dr. Dabas has brought about a paradigm shift in the field of surgical oncology. As the Vice Chairman – Oncology at BLK-Max Super Specialty Hospital in New Delhi, India, his expertise and contributions to the field have garnered worldwide recognition.
The Master of Robotic Surgical Oncology
Dr. Surender Kumar Dabas stands at the forefront of Robotic Surgical Oncology in India. Having successfully performed more than 20,000 complex cancer surgeries, including an astounding 2,500 robotic surgeries, he has established himself as a master of his craft. Dr. Dabas has not only pushed the boundaries of what is possible in surgical oncology but has also become an international mentor for Robotic Onco Surgeries.
Qualifications
Dr. Dabas’s qualifications speak volumes about his commitment to excellence and his insatiable thirst for knowledge. With an MBBS, MS (General Surgery), and DNB (Surgical Oncology) to his credit, he possesses a solid educational foundation that serves as a bedrock for his remarkable career.
Expertise
Dr. Dabas has been actively involved in teaching and spreading awareness about robotic surgeries across India. With a strong focus on Head & Neck Onco Surgeries, he has performed the maximum number of such procedures in Asia. In addition, he is the only cancer surgeon in India to have received training and certification from the University of Chicago for Robotic Pancreatic Surgery. Dr. Dabas’s extensive expertise has led to his appointment as the Vice President of the International Guild of Robotic & Endoscopic Head & Neck Surgery.
Dr. Dabas’s remarkable career spans various prestigious institutions. Prior to his current position at BLK-Max Super Specialty Hospital, he served as the Director of Head & Neck and Thoracic Services at Fortis Memorial Research Institute and Fortis Hospital, Shalimar Bagh, Delhi. He also held the position of Chief of Head & Neck Oncology and Robotic Surgery at Rajiv Gandhi Cancer Institute & Research Centre, Delhi. These roles not only showcased his leadership abilities but also solidified his reputation as a leading figure in the field.
Areas of Specialization
With a passion for innovation and patient care, Dr. Surender Kumar Dabas has developed expertise in several areas of robotic surgical oncology. His areas of specialization include Robotic Scarless Head & Neck Cancer Surgery, Robotic Esophageal & Lung Cancer Surgery, Robotic Pancreatic & Colorectal Surgery, and Robotic Prostate, Bladder & Kidney Cancer Surgery. This diverse skill set allows him to provide comprehensive and personalized treatment options to his patients.
Contributions to Medical Science
Beyond his clinical practice, Dr. Surender Kumar Dabas is a prolific researcher and thought leader in the field of surgical oncology. He has authored many scientific articles published in both national and international journals, showcasing his commitment to advancing the field. Additionally, his expertise has been sought after at various medical conferences, where he has shared his insights and findings with fellow healthcare professionals.
Recognitions and Memberships
Dr. Dabas’s contributions have earned him recognition and accolades throughout his career. Notably, he was awarded a gold medal in Pathology for his exceptional performance in the 2nd Professional MBBS Examination. Furthermore, he holds executive council memberships with esteemed organizations such as the International Guild of Robotic & Endoscopic Head-Neck Surgeons (IGREHNS), the Foundation of Head-Neck Oncology (FHNO), and the Indian Association of Surgical Oncology (IASO). These memberships reflect his commitment to staying at the forefront of advancements in surgical oncology.